Astrazeneca PLC AZN
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Gross profit | $48.1B | +10% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Net income | $10.2B | +45% | FY ending Dec 31, 2025 |
| Research & development | $14.2B | +5% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 1 open-market buy ($3,249) and 1 sale ($2.2M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Mani SharmaSee Remarks | Bought | 20 | $160.57 | $3,249 | Aug 8, 2026 |
| Mani SharmaSee Remarks | Sold | 11,893 | $185.78 | $2.2M | May 20, 2026 |
Other insider moves (7): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Mani SharmaSee remarks | Award | 2 | $159.80 | $320 | Oct 6, 2026 |
| Mani SharmaSee Remarks | Award | 1 | $162.60 | $163 | Sep 8, 2026 |
| Mani SharmaSVP, Group Controller | Award | 2 | $163.34 | $327 | Aug 6, 2026 |
| Mani SharmaSee Remarks | Award | 2 | $190.43 | $381 | Jul 6, 2026 |
| Mani SharmaSee Remarks | Award | 1 | $179.75 | $180 | Jun 8, 2026 |
| Mani SharmaSee Remarks | Award | 1 | $186.28 | $186 | May 6, 2026 |
| Mani SharmaSee Remarks | Award | 1 | $196.03 | $196 | Apr 7, 2026 |
Trades by members of Congress
5 members reported 9 buys and 5 sales since Oct 29, 2024. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Julia Letlow R | Bought | $1,001–$15K | Dec 8, 2025 | Jan 13, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Dec 18, 2025 | Jan 12, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Nov 19, 2025 | Dec 15, 2025 | Self |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 31, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Oct 21, 2025 | Nov 18, 2025 | Self |
| Val T. Hoyle D | Sold | $1,001–$15K | Sep 23, 2025 | Oct 10, 2025 | Spouse |
| Val T. Hoyle D | Bought | $1,001–$15K | Oct 29, 2024 | Sep 12, 2025318 days later | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jul 22, 2025 | Aug 13, 2025 | Spouse |
| Lisa C. McClain R | Sold some | $1,001–$15K | Jun 17, 2025 | Aug 13, 202557 days later | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jun 9, 2025 | Aug 13, 202565 days later | Spouse |
| Bruce Westerman R | Sold | $1,001–$15K | Apr 21, 2025 | May 12, 2025 | Self |
| Bruce Westerman R | Bought | $1,001–$15K | Mar 3, 2025 | Apr 16, 2025 | Self |
Latest SEC filings
- News filing (foreign) 6-K · Oct 27, 2026
- News filing (foreign) 6-K · Oct 22, 2026
- News filing (foreign) 6-K · Oct 5, 2026
- News filing (foreign) 6-K · Oct 2, 2026
- News filing (foreign) 6-K · Oct 1, 2026
- News filing (foreign) 6-K · Oct 1, 2026
- News filing (foreign) 6-K · Sep 29, 2026
- News filing (foreign) 6-K · Sep 23, 2026
- News filing (foreign) 6-K · Sep 21, 2026
- News filing (foreign) 6-K · Sep 21, 2026
- News filing (foreign) 6-K · Sep 18, 2026
- News filing (foreign) 6-K · Sep 15, 2026
- News filing (foreign) 6-K · Sep 15, 2026
- News filing (foreign) 6-K · Sep 14, 2026
- News filing (foreign) 6-K · Sep 8, 2026
- News filing (foreign) 6-K · Sep 8, 2026
- News filing (foreign) 6-K · Sep 1, 2026
- News filing (foreign) 6-K · Sep 1, 2026
- News filing (foreign) 6-K · Sep 1, 2026
- News filing (foreign) 6-K · Sep 1, 2026
- News filing (foreign) 6-K · Sep 1, 2026
- News filing (foreign) 6-K · Sep 1, 2026
- News filing (foreign) 6-K · Sep 1, 2026
- News filing (foreign) 6-K · Aug 27, 2026
- News filing (foreign) 6-K · Aug 25, 2026
About Astrazeneca PLC
Business description
- Industry
- Pharmaceutical Preparations
- Sector
- Life Sciences
- Headquarters
- Cambridge
- Incorporated in
- United Kingdom
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- Formerly
- ZENECA GROUP PLC
- SEC company number (CIK)
- 901832
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.